These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. Saharinen J; Taipale J; Monni O; Keski-Oja J J Biol Chem; 1998 Jul; 273(29):18459-69. PubMed ID: 9660815 [TBL] [Abstract][Full Text] [Related]
4. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. Saharinen J; Taipale J; Keski-Oja J EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200 [TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Taipale J; Saharinen J; Keski-Oja J Adv Cancer Res; 1998; 75():87-134. PubMed ID: 9709808 [TBL] [Abstract][Full Text] [Related]
18. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708 [TBL] [Abstract][Full Text] [Related]
19. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Tatti O; Vehviläinen P; Lehti K; Keski-Oja J Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101 [TBL] [Abstract][Full Text] [Related]
20. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Munger JS; Harpel JG; Giancotti FG; Rifkin DB Mol Biol Cell; 1998 Sep; 9(9):2627-38. PubMed ID: 9725916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]